Clinical Trial

Catheter Ablation Using a Novel Navigation and Imaging System

Study acronym: ENVIsIoN
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).
Protocol Amendment History 8 changes
notable Primary completion pushed: 2027-10-01 -> 2027-11-01 2026-07-08
minor Completion pushed: 2027-10-01 -> 2027-11-01 2026-07-08
notable Primary completion pushed: 2027-09-01 -> 2027-10-01 2026-06-11
minor Completion pushed: 2027-09-01 -> 2027-10-01 2026-06-11
notable Primary completion pushed: 2027-08-01 -> 2027-09-01 2026-05-08
minor Completion pushed: 2027-08-01 -> 2027-09-01 2026-05-08
notable Primary completion pushed: 2027-07-01 -> 2027-08-01 2026-04-15
minor Completion pushed: 2027-07-01 -> 2027-08-01 2026-04-15
Trial Details
NCT Number NCT06895187
Lead Sponsor LUMA Vision Ltd.
Conditions Paroxysmal Atrial Fibrillation
Enrollment 100 participants
Start Date 2026-11-01
Primary Completion 2027-11-01 (estimated)
Study Completion 2027-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07